tiprankstipranks
Trending News
More News >
Benitec Biopharma Ltd (BNTC)
NASDAQ:BNTC
US Market

Benitec Biopharma (BNTC) Income Statement

Compare
316 Followers

Benitec Biopharma Income Statement

Last quarter (Q1 2026), Benitec Biopharma's total revenue was AU$0.00, a decrease of ― from the same quarter last year. In Q1, Benitec Biopharma's net income was AU$-13.56M. See Benitec Biopharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
AU$ 0.00AU$ 0.00AU$ 75.00KAU$ 73.00KAU$ 59.00K
Gross Profit
AU$ -396.00KAU$ -343.00KAU$ -306.00KAU$ 64.00KAU$ -64.00K
Operating Expenses
AU$ 41.37MAU$ 22.25MAU$ 18.77MAU$ 17.92MAU$ 13.53M
Depreciation and Amortization
AU$ 69.33KAU$ 343.00KAU$ 381.00KAU$ 392.00KAU$ 424.00K
EBITDA
AU$ -41.70MAU$ -21.41MAU$ -19.15MAU$ -17.85MAU$ -13.45M
Operating Income
AU$ -41.77MAU$ -22.60MAU$ -19.08MAU$ -17.85MAU$ -13.60M
Other Income/Expenses
AU$ 3.85MAU$ 847.00KAU$ -481.00KAU$ -354.00KAU$ -286.00K
Pretax Income
AU$ -37.92MAU$ -21.75MAU$ -19.56MAU$ -18.21MAU$ -13.88M
Net Income
AU$ -37.92MAU$ -21.75MAU$ -19.56MAU$ -18.21MAU$ -13.88M
Per Share Metrics
Basic EPS
AU$ -1.05AU$ -2.68AU$ -14.12AU$ -19.31AU$ -27.27
Diluted EPS
AU$ -1.05AU$ -2.68AU$ -14.12AU$ -19.31AU$ -27.27
Weighted Average Shares Outstanding
36.21M 10.26M 1.39M 1.92M 1.01M
Weighted Average Shares Outstanding (Diluted)
36.21M 10.28M 1.39M 1.92M 1.01M
Currency in AUD

Benitec Biopharma Earnings and Revenue History